Newsletters

Emerging Gene Therapies and Targeted Agents for Patients with Hemophilia
Emerging Gene Therapies and Targeted Agents for Patients with Hemophilia
CME, CPE
Steven W. Pipe, MD
Release Date: July 29, 2022
Expiration Date: July 29, 2023
Join Dr. Pipe as he outlines new innovations and findings relative to hemophilia A and B. Topics include gene therapy, anti-tissue factor pathway inhibitors, and other exciting developments in hemophilia.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from CSL Behring, LLC.
Begin, Earn CreditView Only, No Credit
 

© 2022 MediCom Worldwide, Inc. All rights reserved